MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date

Tuesday, June 6, 2017

1:45pm-3:15pm
Tardive syndromes induced by coadministration of tramadol and sertralin

H. Sarac, N. Bozina, N. Henigsberg, L. Bagaric-Krakan (Zagreb, Croatia)

Drug-Induced Movement Disorders  ·  Exhibit Hall C
1:45pm-3:15pm
Targeted overexpression of A53T-alpha-synuclein induces progressive neurodegeneration and electrophysiological changes of noradrenergic locus coeruleus neurons – a preclinical model of Parkinson’s disease

M. Henrich, L. Matschke, A. Stoehr, W.-H. Chiu, B. Lee, F. Geibl, J. Koprich, N. Decher, W. Oertel (Marburg, Germany)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C
1:45pm-3:15pm
Targeting alpha-Synuclein Aggregation for the Treatment of Parkinson’s Disease

E. Tsika, E. Gabellieri, A. Davranche, C. Boudou, M. Ravache, L. Grasso, S. Nampally, H. Haddouk, J. Wettstein, A. Pfeifer, A. Muhs (Lausanne, Switzerland)

Therapy in Movement Disorders  ·  Exhibit Hall C
1:45pm-3:15pm
TETRAS applicability and study design in randomized, placebo controlled clinical trial of Cav3 modulation for essential tremor patients.

Y. Maricich, E. Newbold, R. Elble (Charlottesville, VA, USA)

Tremor  ·  Exhibit Hall C
1:45pm-3:15pm
The Accreditation and Certification of the Movement Disorders Subspecialty

S. O'Shea, L. Gutmann, L. Faulkner (New York, NY, USA)

Education in Movement Disorders  ·  Exhibit Hall C
1:45pm-3:15pm
The AppTUG : a new application for analyzing the Timed Up and Go task in patients with neurological disorders

G. Yahalom, Z. Yekutieli, S. Korn-Israeli, S. Elincx-Benizri, V. Livneh, T. Fay-Karmon, Y. Rubel, S. Hassin-Baer (Ramat-Gan, Israel)

Technology  ·  Exhibit Hall C
1:45pm-3:15pm
The comparison of urine microvesicle reflecting gut microbiome between Parkinson’s disease and healthy control

J. Park, S. Park, W. Jang, J.S. Kim, J. Yoon, E. Oh (Busan, Republic of Korea)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C
1:45pm-3:15pm
The effects of dual task on the finger tapping performance of Parkinson’s disease.

A. Miyake, T. Yamamoto, H. Kawasaki, T. Furuya, T. Fukuoka, K. Takahashi, N. Tamura, N. Araki (irumagun moroyama town, Japan)

Parkinson's Disease: Pathophysiology  ·  Exhibit Hall C
1:45pm-3:15pm
The Huntington’s Disease Health Index Study (HD-HI)

A. Glidden, E. Luebbe, M. Elson, S. Goldenthal, R. Dorsey, C. Heatwole (Rochester, NY, USA)

Huntington's Disease  ·  Exhibit Hall C
1:45pm-3:15pm
The influence of neurorehabilitation on Parkinson medication

V. Tomantschger, A. Tautscher-Basnett, M. Freimueller (Hermagor, Austria)

Therapy in Movement Disorders  ·  Exhibit Hall C
  • «Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 38
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley